• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV-1持续存在的表观遗传机制

Epigenetic Mechanisms of HIV-1 Persistence.

作者信息

Verdikt Roxane, Hernalsteens Olivier, Van Lint Carine

机构信息

Service of Molecular Virology, Department of Molecular Virology (DBM), Université Libre de Bruxelles (ULB), 6041 Gosselies, Belgium.

出版信息

Vaccines (Basel). 2021 May 17;9(5):514. doi: 10.3390/vaccines9050514.

DOI:10.3390/vaccines9050514
PMID:34067608
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8156729/
Abstract

Eradicating HIV-1 in infected individuals will not be possible without addressing the persistence of the virus in its multiple reservoirs. In this context, the molecular characterization of HIV-1 persistence is key for the development of rationalized therapeutic interventions. HIV-1 gene expression relies on the redundant and cooperative recruitment of cellular epigenetic machineries to -regulatory proviral regions. Furthermore, the complex repertoire of HIV-1 repression mechanisms varies depending on the nature of the viral reservoir, although, so far, few studies have addressed the specific regulatory mechanisms of HIV-1 persistence in other reservoirs than the well-studied latently infected CD4 T cells. Here, we present an exhaustive and updated picture of the heterochromatinization of the HIV-1 promoter in its different reservoirs. We highlight the complexity, heterogeneity and dynamics of the epigenetic mechanisms of HIV-1 persistence, while discussing the importance of further understanding HIV-1 gene regulation for the rational design of novel HIV-1 cure strategies.

摘要

如果不解决病毒在其多个储存库中的持续存在问题,就不可能在受感染个体中根除HIV-1。在这种情况下,HIV-1持续存在的分子特征对于合理治疗干预措施的开发至关重要。HIV-1基因表达依赖于细胞表观遗传机制向调节性原病毒区域的冗余和协同募集。此外,HIV-1抑制机制的复杂组成因病毒储存库的性质而异,尽管到目前为止,很少有研究探讨除了经过充分研究的潜伏感染CD4 T细胞之外的其他储存库中HIV-1持续存在的具体调节机制。在这里,我们展示了HIV-1启动子在其不同储存库中的异染色质化的详尽且最新的情况。我们强调了HIV-1持续存在的表观遗传机制的复杂性、异质性和动态性,同时讨论了进一步了解HIV-1基因调控对于合理设计新型HIV-1治愈策略的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/325b/8156729/5ffa90b2975a/vaccines-09-00514-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/325b/8156729/a6a74f3aec97/vaccines-09-00514-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/325b/8156729/fdb5bb64d9a5/vaccines-09-00514-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/325b/8156729/5ffa90b2975a/vaccines-09-00514-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/325b/8156729/a6a74f3aec97/vaccines-09-00514-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/325b/8156729/fdb5bb64d9a5/vaccines-09-00514-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/325b/8156729/5ffa90b2975a/vaccines-09-00514-g003.jpg

相似文献

1
Epigenetic Mechanisms of HIV-1 Persistence.HIV-1持续存在的表观遗传机制
Vaccines (Basel). 2021 May 17;9(5):514. doi: 10.3390/vaccines9050514.
2
Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.HIV-1储存库:在抗病毒免疫反应和抗逆转录病毒疗法存在的情况下病毒持续存在的机制
Annu Rev Immunol. 2000;18:665-708. doi: 10.1146/annurev.immunol.18.1.665.
3
Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3.核基质蛋白 MATR3 对 HIV-1 基因在复制和潜伏激活期间转录后调控
mBio. 2018 Nov 13;9(6):e02158-18. doi: 10.1128/mBio.02158-18.
4
Epigenetic control of HIV-1 post integration latency: implications for therapy.HIV-1整合后潜伏期的表观遗传调控:对治疗的意义
Clin Epigenetics. 2015 Sep 24;7:103. doi: 10.1186/s13148-015-0137-6. eCollection 2015.
5
Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4 T Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy.马拉维若与潜伏 HIV-1 再激活有关,通过抑制性抗逆转录病毒治疗的 HIV 感染者静息 CD4 T 细胞中 NF-κB 的激活。
J Virol. 2018 Apr 13;92(9). doi: 10.1128/JVI.01931-17. Print 2018 May 1.
6
Modeling HIV-1 Latency Using Primary CD4 T Cells from Virally Suppressed HIV-1-Infected Individuals on Antiretroviral Therapy.利用抗逆转录病毒治疗中病毒抑制的 HIV-1 感染者的原代 CD4 T 细胞建立 HIV-1 潜伏期模型。
J Virol. 2019 May 15;93(11). doi: 10.1128/JVI.02248-18. Print 2019 Jun 1.
7
Ultrasensitive HIV-1 p24 Assay Detects Single Infected Cells and Differences in Reservoir Induction by Latency Reversal Agents.超灵敏HIV-1 p24检测法可检测单个感染细胞以及潜伏逆转剂诱导的病毒储存库差异。
J Virol. 2017 Feb 28;91(6). doi: 10.1128/JVI.02296-16. Print 2017 Mar 15.
8
Infectious Virus Persists in CD4 T Cells and Macrophages in Antiretroviral Therapy-Suppressed Simian Immunodeficiency Virus-Infected Macaques.在抗逆转录病毒治疗抑制的感染猴免疫缺陷病毒的猕猴的 CD4 T 细胞和巨噬细胞中持续存在传染性病毒。
J Virol. 2019 Jul 17;93(15). doi: 10.1128/JVI.00065-19. Print 2019 Aug 1.
9
A Novel Single-Cell FISH-Flow Assay Identifies Effector Memory CD4 T cells as a Major Niche for HIV-1 Transcription in HIV-Infected Patients.一种新型单细胞荧光原位杂交-流式细胞术检测方法确定效应记忆CD4 T细胞是HIV感染患者中HIV-1转录的主要微环境。
mBio. 2017 Jul 11;8(4):e00876-17. doi: 10.1128/mBio.00876-17.
10
Chromatin Regulation and the Histone Code in HIV Latency
.HIV潜伏中的染色质调控与组蛋白密码
Yale J Biol Med. 2017 Jun 23;90(2):229-243. eCollection 2017 Jun.

引用本文的文献

1
Multi-omics single-cell analysis reveals key regulators of HIV-1 persistence and aberrant host immune responses in early infection.多组学单细胞分析揭示了HIV-1早期感染持续存在和宿主异常免疫反应的关键调节因子。
Elife. 2025 Aug 21;14:RP104856. doi: 10.7554/eLife.104856.
2
Genome-wide CRISPR knockout screen identifies activating transcription factor (ATF1) as an activator of HIV gene expression.全基因组CRISPR敲除筛选确定激活转录因子(ATF1)为HIV基因表达的激活剂。
mBio. 2025 Aug 13;16(8):e0055725. doi: 10.1128/mbio.00557-25. Epub 2025 Jul 3.
3
Advancements in single-cell techniques for examining the HIV reservoir: pathways to a cure.

本文引用的文献

1
Inhibition of HIV-1 gene transcription by KAP1 in myeloid lineage.在髓系细胞中 KAP1 抑制 HIV-1 基因转录。
Sci Rep. 2021 Jan 29;11(1):2692. doi: 10.1038/s41598-021-82164-w.
2
CBF-1 Promotes the Establishment and Maintenance of HIV Latency by Recruiting Polycomb Repressive Complexes, PRC1 and PRC2, at HIV LTR.CBF-1 通过募集 Polycomb 抑制复合物 PRC1 和 PRC2 于 HIV LTR 促进 HIV 潜伏的建立和维持。
Viruses. 2020 Sep 18;12(9):1040. doi: 10.3390/v12091040.
3
NF-κB-Interacting Long Noncoding RNA Regulates HIV-1 Replication and Latency by Repressing NF-κB Signaling.
用于检测HIV储存库的单细胞技术进展:治愈之路
mBio. 2025 Jul 9;16(7):e0065525. doi: 10.1128/mbio.00655-25. Epub 2025 Jun 9.
4
Epigenetic modifications and immune responses in HIV-infected infants: a narrative review.HIV感染婴儿的表观遗传修饰与免疫反应:一篇叙述性综述
Ann Med Surg (Lond). 2025 Mar 7;87(6):3381-3387. doi: 10.1097/MS9.0000000000003142. eCollection 2025 Jun.
5
ABT-263, a BCL-2 inhibitor, selectively eliminates latently HIV-1-infected cells without viral reactivation.ABT-263,一种BCL-2抑制剂,可在不激活病毒的情况下选择性清除潜伏感染HIV-1的细胞。
PLoS One. 2025 May 20;20(5):e0322962. doi: 10.1371/journal.pone.0322962. eCollection 2025.
6
RYBP promotes HIV-1 latency through promoting H2AK119ub and decreasing H3K4me3.RYBP通过促进H2AK119泛素化和减少H3K4me3来促进HIV-1潜伏。
Cell Commun Signal. 2025 May 13;23(1):222. doi: 10.1186/s12964-025-02221-z.
7
Expression of HIV from a 1-LTR circular DNA in the absence of integration.在缺乏整合的情况下,HIV从1-长末端重复序列环状DNA中的表达。
Retrovirology. 2025 Mar 17;22(1):2. doi: 10.1186/s12977-025-00658-1.
8
Harnessing antiviral RNAi therapeutics for pandemic viruses: SARS-CoV-2 and HIV.利用抗病毒RNA干扰疗法治疗大流行病毒:严重急性呼吸综合征冠状病毒2(SARS-CoV-2)和人类免疫缺陷病毒(HIV)
Drug Deliv Transl Res. 2025 Jan 20. doi: 10.1007/s13346-025-01788-x.
9
CBP/p300 lysine acetyltransferases inhibit HIV-1 expression in latently infected T cells.CBP/p300赖氨酸乙酰转移酶抑制潜伏感染T细胞中的HIV-1表达。
iScience. 2024 Oct 28;27(12):111244. doi: 10.1016/j.isci.2024.111244. eCollection 2024 Dec 20.
10
The impact of sex on HIV immunopathogenesis and therapeutic interventions.性对 HIV 免疫发病机制和治疗干预的影响。
J Clin Invest. 2024 Sep 17;134(18):e180075. doi: 10.1172/JCI180075.
NF-κB 相互作用的长非编码 RNA 通过抑制 NF-κB 信号来调节 HIV-1 的复制和潜伏期。
J Virol. 2020 Aug 17;94(17). doi: 10.1128/JVI.01057-20.
4
PIWIL4 Maintains HIV-1 Latency by Enforcing Epigenetically Suppressive Modifications on the 5' Long Terminal Repeat.PIWIL4 通过对 5' 长末端重复序列施加表观遗传抑制修饰来维持 HIV-1 潜伏期。
J Virol. 2020 May 4;94(10). doi: 10.1128/JVI.01923-19.
5
Exploring histone loading on HIV DNA reveals a dynamic nucleosome positioning between unintegrated and integrated viral genome.探索 HIV DNA 上的组蛋白装载情况揭示了未整合和整合病毒基因组之间动态的核小体定位。
Proc Natl Acad Sci U S A. 2020 Mar 24;117(12):6822-6830. doi: 10.1073/pnas.1913754117. Epub 2020 Mar 11.
6
Epigenetic crosstalk in chronic infection with HIV-1.HIV-1 慢性感染中的表观遗传串扰。
Semin Immunopathol. 2020 Apr;42(2):187-200. doi: 10.1007/s00281-020-00783-3. Epub 2020 Feb 11.
7
Current Status of Latency Reversing Agents Facing the Heterogeneity of HIV-1 Cellular and Tissue Reservoirs.面对HIV-1细胞和组织储存库异质性的潜伏期逆转剂的现状
Front Microbiol. 2020 Jan 24;10:3060. doi: 10.3389/fmicb.2019.03060. eCollection 2019.
8
Longitudinal variation in human immunodeficiency virus long terminal repeat methylation in individuals on suppressive antiretroviral therapy.接受抑制性抗逆转录病毒疗法个体的人类免疫缺陷病毒长末端重复序列甲基化的纵向变化。
Clin Epigenetics. 2019 Sep 13;11(1):134. doi: 10.1186/s13148-019-0735-9.
9
Applications of CRISPR/Cas9 tools in deciphering the mechanisms of HIV-1 persistence.CRISPR/Cas9 工具在破解 HIV-1 持续存在机制中的应用。
Curr Opin Virol. 2019 Oct;38:63-69. doi: 10.1016/j.coviro.2019.07.004. Epub 2019 Sep 8.
10
Spatially clustered loci with multiple enhancers are frequent targets of HIV-1 integration.具有多个增强子的空间聚集基因座是 HIV-1 整合的常见靶点。
Nat Commun. 2019 Sep 6;10(1):4059. doi: 10.1038/s41467-019-12046-3.